Dose serum mannose binding lectin (MBL) influence allergic disorders? Source: Eur Respir J 2004; 24: Suppl. 48, 395s Year: 2004
Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
Mannan-binding lectin (MBL) structural gene mutations, promoter polymorphism and circulating protein levels in pulmonary tuberculosis Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003
Soluble NKG2D ligand expression associates with smoking, presence of COPD, and presence of lung cancer: The "EMICON" study Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010
Mannan binding lectin (MBL) is present in human lung tissue and is expressed by human lung mast cells Source: Eur Respir J 2003; 22: Suppl. 45, 10s Year: 2003
Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease Source: ERJ Open Res, 4 (3) 00033-2018; 10.1183/23120541.00033-2018 Year: 2018
Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Mannose binding lectin deficiency is associated with disease severity in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011
Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
The effect of MRP1 variants and the intensity of MRP1 protein expression in bronchial biopsies on lung function decline in COPD Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
Reduced glucocorticoid receptor binding affinity in blood lymphocytes and monocytes of COPD patients Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Increased levels of human myeloperxidase (MPO) and neutrophil lipocalin (HNL/NGAL) in childhood asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Correlation between change in lung density and lung function parameters in treated alpha-1 protease inhibitor (A1-PI) deficiency Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016
The Gender-Age-Physiology (GAP) Index enhanced with KL-6 serum level for predicting disease progression in interstitial lung diseases (ILD). Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
Glucocorticoid receptor-binding characteristics in severe asthma Source: Eur Respir J 2003; 21: 985-988 Year: 2003
Leptin receptor polymorphisms and lung function decline in COPD Source: Eur Respir J 2009; 34: 103-110 Year: 2009
Mannose binding lectin - HYPD allele is associated with frequent exacerbation in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
The clinical relevance of mannose-binding lectin (MBL) in long term survival of lung transplant recipients Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013